Versant Capital Management, Inc Arcturus Therapeutics Holdings Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 61 shares of ARCT stock, worth $825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 198
69.19%
Holding current value
$825
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
163Shares Held
26.5MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$63.6 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$35.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.01MShares$27.2 Million0.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.93MShares$26.1 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$26.1 Million0.27% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $360M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...